Non-association of IL-16 rs4778889 T/C polymorphism with cancer risk in Asians: A meta-analysis

6Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The IL-16 rs4778889 T/C polymorphism is associated with cancer risk. However, the results are conflicting. We performed this meta-analysis to derive a more precise estimation of the relationship. A comprehensive literature search was performed using PubMed, Embase and Web of Science databases. Odds ratio (OR) and 95% confidence interval (CI) were used to assess the strength of association. A total of 6 studies including 1,603 cases and 2,342 controls were identified. With all studies involved, results showed no statistically significant association between IL-16 rs4778889 T/C polymorphism and cancer risk (CC vs. CT+TT: OR=0.74, 95%CI: 0.55-1.02, Ph=0.15; CC+CT vs. TT: OR=0.89, 95%CI: 0.72-1.10, Ph =0.03; CC vs. TT: OR=0.73, 95%CI: 0.53-1.00, Ph =0.08; CT vs. TT: OR=0.91, 95%CI: 0.79-1.05, Ph =0.08; C vs. T: OR=0.89, 95%CI: 0.74-1.07, Ph =0.02). In addition, the results were not changed when studies were stratified by cancer type. However, to verify our findings, it is essential to perform more well-designed studies with larger sample sizes in the future.

Cite

CITATION STYLE

APA

Xu, L. L., Song, Z. C., Shang, K., Zhao, L. Q., & Zhu, Z. S. (2014). Non-association of IL-16 rs4778889 T/C polymorphism with cancer risk in Asians: A meta-analysis. Asian Pacific Journal of Cancer Prevention, 15(2), 803–805. https://doi.org/10.7314/APJCP.2014.15.2.803

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free